STOCK TITAN

Nurix Therapeutics: Vestal Point reports 6.4% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Nurix Therapeutics, Inc. (NRIX) is the subject of an amended ownership report stating that Vestal Point Capital, LP and Ryan Wilder reported shared beneficial ownership of 7,025,000 common shares, or 6.4% of the class. Vestal Point Capital is the investment adviser to the Vestal Point Fund and Account, and Wilder is its Chief Investment Officer and Managing Partner. The Fund and Account directly hold the reported shares and have the right to receive dividends or direct the receipt of sale proceeds. Both reporting persons reported shared voting and dispositive power over the shares. NRIX had 109,249,814 common shares outstanding as of September 30, 2026. The reporting persons state that the report is not an admission that they are beneficial owners for purposes of Section 13 of the Securities Exchange Act of 1934.

Shared beneficial ownership 7,025,000 shares Reported by Vestal Point Capital, LP and Ryan Wilder
Percent of class 6.4% Based on 109,249,814 common shares outstanding as of September 30, 2026
Common shares outstanding 109,249,814 shares As of September 30, 2026
beneficially owned regulatory
"Aggregate amount beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power regulatory
"Shared voting power over the reported shares"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared dispositive power over the reported shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NRIX shares did Vestal Point Capital and Ryan Wilder report?

They each reported shared beneficial ownership of 7,025,000 Nurix common shares, representing 6.4% of the class.

Who has voting and disposition authority over the NRIX shares?

Vestal Point Capital, LP and Ryan Wilder each reported shared voting and shared dispositive power over the 7,025,000 shares. The shares are held directly by the Vestal Point Fund and Account, which have the right to receive dividends or direct the receipt of sale proceeds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





67080M103

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Vestal Point Capital, LP
Signature:/s/ Ryan Wilder
Name/Title:By: Vestal Point Capital, LLC, General Partner, By: Ryan Wilder, Chief Investment Officer and Managing Partner
Date:11/16/2026
Ryan Wilder
Signature:/s/ Ryan Wilder
Name/Title:Ryan Wilder, Individually
Date:11/16/2026

Keep reading